Literature DB >> 33206330

Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer.

M Li1, Q Li2, Q Yin3, Y Wang4, J M Shang5, L H Wang6.   

Abstract

PURPOSE: To evaluate the clinical value of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer (BC).
METHODS: 129 patients with BC and 50 patients with benign breast lesions were selected. They were scanned by color Doppler ultrasound on the breast. The relative expression of miR-21 and miR-27a in plasma was detected by real-time fluorescence quantitative PCR. The clinical value of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of BC was analyzed retrospectively.
RESULTS: Two-dimensional ultrasound images of BC showed irregular shape, unclear boundary, burr-like edge, uneven internal echo, weakened rear echo, microcalcification, aspect ratio > 1 and axillary lymph node metastasis. The grade of blood flow signal was improved, mainly in grade II and above, which was statistically different from that of benign control group (P < 0.001). The relative expression of plasma miR-21 and miR-27a in breast cancer group was significantly higher than that in benign control group (P < 0.001). The relative expressions of plasma miR-21 and miR-27a in breast cancer group were significantly correlated with histological grade, clinical stage, lymph node metastasis and postoperation. The relative expression levels of miR-21 and miR-27a in plasma of patients with low histological grade (grade III), high clinical stage (stage III, IV) and lymph node metastasis before operation were significantly higher than those in patients with high histological grade (grade I, II), low clinical stage (stage I, II) and no lymph node metastasis after operation (P < 0.01). The sensitivity, accuracy and negative predictive value of ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of BC were significantly higher than those of each single examination.
CONCLUSIONS: Color Doppler ultrasound combined with plasma miR-21 and miR-27a can significantly improve the diagnostic efficiency of BC, which is beneficial to early diagnosis and early clinical intervention.

Entities:  

Keywords:  Breast cancer; Color Doppler ultrasound; Combined detection; Plasma miR-21 and miR

Year:  2020        PMID: 33206330     DOI: 10.1007/s12094-020-02501-9

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  4 in total

Review 1.  Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.

Authors:  Fei Pan; Hui Mao; Ling Deng; Guangchao Li; Peiliang Geng
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Breast cancer. Screening criteria.

Authors:  D Zob; M Vasilescu; Mi Gruia; R Anghel
Journal:  Chirurgia (Bucur)       Date:  2013 Jul-Aug

3.  High-frequency breast ultrasound for the detection of microcalcifications and associated masses in BI-RADS 4a patients.

Authors:  Frank Stöblen; Solveig Landt; Rami Ishaq; Ruth Stelkens-Gebhardt; Mahdi Rezai; Per Skaane; Jens-Uwe Blohmer; Jalid Sehouli; Sherko Kümmel
Journal:  Anticancer Res       Date:  2011-08       Impact factor: 2.480

4.  miR‑27a promotes human breast cancer cell migration by inducing EMT in a FBXW7‑dependent manner.

Authors:  Guobin Jiang; Weiwu Shi; Hongyan Fang; Xiaohua Zhang
Journal:  Mol Med Rep       Date:  2018-10-24       Impact factor: 2.952

  4 in total
  3 in total

1.  Application of Color Doppler Ultrasound in Microscopic Imaging Diagnosis of Adenomyosis.

Authors:  Jianchang Zhu; Shuang Liu; Dandan Gao
Journal:  Scanning       Date:  2022-05-31       Impact factor: 1.750

Review 2.  miRNAs in Cancer (Review of Literature).

Authors:  Beata Smolarz; Adam Durczyński; Hanna Romanowicz; Krzysztof Szyłło; Piotr Hogendorf
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

3.  Role of Ultrasound Imaging in the Prediction of TRIM67 in Brain Metastases From Breast Cancer.

Authors:  Zhidong Xuan; Ting Ma; Yue Qin; Yajie Guo
Journal:  Front Neurol       Date:  2022-06-20       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.